Tarsons Products Ltd

Tarsons Products Ltd

₹ 465 -1.31%
25 Apr 12:06 p.m.
About

Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others' including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations, Diagnostic companies, and hospitals[1]

Key Points

India’s Leading Labware Company
One of the leading Indian labware company engaged in designing, development, manufacturing and marketing of consumables, reusables and others (including benchtop
equipment & instruments) [1]

  • Market Cap 2,474 Cr.
  • Current Price 465
  • High / Low 646 / 390
  • Stock P/E 24.6
  • Book Value 92.1
  • Dividend Yield 0.00 %
  • ROCE 35.3 %
  • ROE 27.4 %
  • Face Value 2.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Miscellaneous Industry: Miscellaneous

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
60 68 69 76 71 85
30 33 32 38 38 41
Operating Profit 31 35 37 38 33 44
OPM % 51% 52% 53% 51% 47% 52%
2 1 2 1 2 3
Interest 1 1 1 2 1 0
Depreciation 3 3 5 5 5 7
Profit before tax 28 32 33 34 29 39
Tax % 26% 25% 26% 26% 26% 25%
21 24 25 25 21 29
EPS in Rs 1,095.21 1,225.81 4.88 4.89 4.04 5.54
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022
229 301
125 148
Operating Profit 103 153
OPM % 45% 51%
5 8
Interest 3 4
Depreciation 14 22
Profit before tax 92 135
Tax % 25% 25%
69 101
EPS in Rs 3,583.25 18.92
Dividend Payout % 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 31%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 46%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -12%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 27%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022
Equity Capital 0 11
Reserves 244 479
34 22
18 33
Total Liabilities 296 544
120 189
CWIP 22 32
Investments 0 0
153 323
Total Assets 296 544

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022
68 83
-64 -138
-27 130
Net Cash Flow -23 75

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022
Debtor Days 75 79
Inventory Days 277 478
Days Payable 35 75
Cash Conversion Cycle 317 482
Working Capital Days 108 150
ROCE % 35%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
47.30% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31%
9.33% 9.12% 9.33% 9.90% 9.60% 9.16% 8.64% 7.85% 6.83% 8.16%
6.33% 7.76% 8.06% 8.13% 8.52% 8.45% 7.38% 3.15% 2.60% 0.17%
37.04% 35.82% 35.31% 34.67% 34.59% 35.09% 36.67% 41.68% 43.27% 44.36%
No. of Shareholders 1,59,8911,25,7141,12,2271,07,0111,07,9451,05,3041,07,4401,08,2361,07,5641,02,866

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents